Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Alcon Research |
---|---|
Information provided by: | Alcon Research |
ClinicalTrials.gov Identifier: | NCT00404937 |
The purpose of this study is to compare the new formulation of Tobradex to the current approved formulation
Condition | Intervention | Phase |
---|---|---|
Post-Surgical Inflammation |
Drug: Tobradex (Antibiotic steroid combination) |
Phase III |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Single Blind, Active Control, Parallel Assignment, Safety/Efficacy Study |
Official Title: | Tobradex BID Compared to TOBRADEX and TOBREX/Vehicle |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Study ID Numbers: | C-05-60 |
Study First Received: | November 28, 2006 |
Last Updated: | September 10, 2007 |
ClinicalTrials.gov Identifier: | NCT00404937 |
Health Authority: | France: Institutional Ethical Committee |
Tobramycin Inflammation |
Pathologic Processes |